Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-041"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20060613.6.2-041"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, Commissioner, I should like to start by joining with those who have thanked and congratulated our rapporteur, Mr Buzek, and by saying how disappointed I am at this budget of EUR 54 billion or so over seven years, which we had hoped would be more ambitious, much more ambitious, in the interests of the Europe of excellence of which we are all dreaming. In this regard, the creation of the European Research Council is absolutely essential. As others have dwelt upon it at length before me, including Mr Brunetta, I will not go into the details now.
Another sensitive area for Europe is energy, and the various schemes thought up for moving on from the petroleum era, with a package of EUR 2 385 000 000, the budget retained by the Committee on Industry, Research and Energy, which gives priority to renewable energy. Biofuels and biomass form part of the solution, which also needs to involve education to reduce consumption.
In the opinion of the majority of my group, this European desire to look beyond the long term and to go down the path of scientific freedom to help those who most need it goes through the continuity of European funding for embryonic stem cell research. This research must be funded in the same way as research on stem cells from adults or from umbilical cord blood. That is what Amendment 66 proposes.
The only real compromise from the Committee on Industry, Research and Energy, which is supported by Mr Busquin, Mrs Gutiérrez, Mrs Locatelli and a whole series of speakers before me, as well as by myself and a large proportion of my group, relates to the danger of a deadline for the eligibility of lines, because it would be – as the Commissioner reminded us – a real bombshell for European researchers.
It is this freedom of choice that I am defending, the choice of healing in the face of death, of the hope provided by research on embryos for patients suffering from one of 6 000 rare diseases. From time to time we need to dot the i's and cross the t's. What we are talking about here, what we care about, is research and compassion, not fantasies of cloning out of
which is the impression one gets sometimes.
More than 70% of European citizens are asking us – are asking you, Commissioner – not to hinder such a promising area of research. That figure comes from the Eurobarometer of 2005, and I agree with Mr Chatzimarkakis regarding the failure to publish the figures from 2006, which I know is not down to you. What is the Presidency waiting for before it authorises the publication of these figures?"@en1
|
| lpv:unclassifiedMetadata |
"Brave New World"1
|
Named graphs describing this resource:
The resource appears as object in 2 triples